Dr Bruna Panizzutti Parry

Cannabinoid receptor gene polymorphisms and cognitive performance in patients with schizophrenia and controls

R Ferretjans, R de Souza, B Panizzutti, P Ferrari, L Mantovani, S de Campos-Carli, R Santos, F Guimarães, A Teixeira, C Gama, J Salgado

(2022), Vol. 44, pp. 26-34, Brazilian Journal of Psychiatry, São Paulo, Brazil, C1

Common effects of bipolar disorder medications on expression quantitative trait loci genes

T Truong, C Bortolasci, S Kidnapillai, B Spolding, B Panizzutti, Z Liu, B Watmuff, J Kim, O Dean, M Richardson, M Berk, K Walder

(2022), Vol. 150, pp. 105-112, Journal of Psychiatric Research, Amsterdam, The Netherlands, C1

Effects of psychotropic drugs on ribosomal genes and protein synthesis

Zoe Liu, Trang Truong, Chiara Bortolasci, Briana Spolding, Bruna Panizzutti, Courtney Swinton, Jee Kim, Srisaiyini Kidnapillai, Mark Richardson, Laura Gray, Olivia Dean, Sean McGee, Michael Berk, Ken Walder

(2022), Vol. 23, pp. 7180-7180, International Journal of Molecular Sciences, Basel, Switzerland, C1

Integrative analyses of transcriptomes to explore common molecular effects of antipsychotic drugs

Trang Truong, Chiara Bortolasci, Srisaiyini Kidnapillai, Briana Spolding, Bruna Panizzutti, Zoe Liu, Jee Kim, Olivia Dean, Mark Richardson, Michael Berk, Ken Walder

(2022), Vol. 23, pp. 7508-7508, International Journal of Molecular Sciences, Basel, Switzerland, C1

Repurposing Drugs via Network Analysis: Opportunities for Psychiatric Disorders

T Truong, B Panizzutti, J Kim, K Walder

(2022), Vol. 14, Pharmaceutics, Switzerland, C1

Transcriptional modulation of the hippo signaling pathway by drugs used to treat bipolar disorder and schizophrenia

B Panizzutti, C Bortolasci, B Spolding, S Kidnapillai, T Connor, M Richardson, T Truong, Z Liu, G Morris, L Gray, J Kim, O Dean, M Berk, K Walder

(2021), Vol. 22, International Journal of Molecular Sciences, Switzerland, C1

Biological mechanism(S) underpinning the association between antipsychotic drugs and weight gain

B Panizzutti, C Bortolasci, B Spolding, S Kidnapillai, T Connor, M Richardson, T Truong, Z Liu, L Gray, J Kim, O Dean, M Berk, K Walder

(2021), Vol. 10, Journal of Clinical Medicine, Switzerland, C1

The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder

S Kidnapillai, C Bortolasci, M Udawela, B Panizzutti, B Spolding, T Connor, A Sanigorski, O Dean, T Crowley, S Jamain, L Gray, E Scarr, M Leboyer, B Dean, M Berk, K Walder

(2020), Vol. 21, pp. 775-783, World Journal of Biological Psychiatry, England, C1

Drugs used to treat bipolar disorder act via microRNAs to regulate expression of genes involved in neurite outgrowth

S Kidnapillai, B Wade, C Bortolasci, B Panizzutti, B Spolding, T Connor, T Crowley, S Jamain, L Gray, M Leboyer, M Berk, K Walder

(2020), Vol. 34, pp. 370-379, Journal of Psychopharmacology, United States, C1

Transcriptional effects of psychoactive drugs on genes involved in neurogenesis

C Bortolasci, B Spolding, S Kidnapillai, T Connor, T Truong, Z Liu, B Panizzutti, M Richardson, L Gray, M Berk, O Dean, K Walder

(2020), Vol. 21, pp. 1-19, International Journal of Molecular Sciences, Switzerland, C1

Reduction of hippocampal IL-6 levels in LPS-injected rats following acute exendin-4 treatment

L Géa, E da Rosa, B Panizzutti, É de Aguiar, L de Oliveira, P Ferrari, A Piato, R Gomez, R Colombo, A Rosa

(2020), Vol. 393, pp. 1303-1311, Naunyn-Schmiedeberg's Archives of Pharmacology, Germany, C1

Drugs used in the treatment of bipolar disorder and their effects on cholesterol biosynthesis - a possible therapeutic mechanism

S Kidnapillai, C Bortolasci, B Panizzutti, B Spolding, T Connor, K Bonifacio, A Sanigorski, O Dean, T Crowley, S Jamain, L Gray, M Leboyer, M Berk, K Walder

(2019), Vol. 20, pp. 766-777, World Journal of Biological Psychiatry, London, Eng., C1

Mechanisms underpinning the polypharmacy effects of medications in psychiatry

C Bortolasci, B Spolding, E Callaly, S Martin, B Panizzutti, S Kidnapillai, T Connor, K Hasebe, M Mohebbi, O Dean, S McGee, S Dodd, L Gray, M Berk, K Walder

(2018), Vol. 21, pp. 582-591, International Journal of Neuropsychopharmacology, England, C1

Mediator effects of parameters of inflammation and neurogenesis from a N-acetyl cysteine clinical-trial for bipolar depression

B Panizzutti, C Bortolasci, K Hasebe, S Kidnapillai, L Gray, K Walder, M Berk, M Mohebbi, S Dodd, C Gama, P Magalhães, S Cotton, F Kapczinski, A Bush, G Malhi, O Dean

(2018), Vol. 30, pp. 334-341, Acta Neuropsychiatrica, England, C1

Telomere Length and CCL11 Levels are Associated with Gray Matter Volume and Episodic Memory Performance in Schizophrenia: Evidence of Pathological Accelerated Aging

L Czepielewski, R Massuda, B Panizzutti, L Grun, F Barbé-Tuana, A Teixeira, D Barch, C Gama

(2018), Vol. 44, pp. 158-167, Schizophrenia Bulletin, United States, C1

Adjunctive N-acetylcysteine in depression: Exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factor

K Hasebe, L Gray, C Bortolasci, B Panizzutti, M Mohebbi, S Kidnapillai, B Spolding, K Walder, M Berk, G Malhi, S Dodd, O Dean

(2017), Vol. 29, pp. 337-346, Acta Neuropsychiatrica, England, C1

Shortened telomere length in bipolar disorder: A comparison of the early and late stages of disease

F Barbé-Tuana, M Parisi, B Panizzutti, G Fries, L Grun, F Guma, F Kapczinski, M Berk, C Gama, A Rosa

(2016), Vol. 38, pp. 281-286, Revista Brasileira de Psiquiatria, Brazil, C1

Telomere length in subjects with schizophrenia, their unaffected siblings and healthy controls: Evidence of accelerated aging

L Czepielewski, R Massuda, B Panizzutti, E da Rosa, D de Lucena, D Macêdo, L Grun, F Barbé-Tuana, C Gama

(2016), Vol. 174, pp. 39-42, Schizophrenia Research, Netherlands, C1

Increased serum levels of eotaxin/CCL11 in late-stage patients with bipolar disorder: An accelerated aging biomarker?

B Panizzutti, C Gubert, A Schuh, P Ferrari, G Bristot, G Fries, R Massuda, J Walz, N Rocha, M Berk, A Teixeira, C Gama

(2015), Vol. 182, pp. 64-69, Journal of affective disorders, Amsterdam, The Netherlands, C1

Progesterone and its metabolites as therapeutic targets in psychiatric disorders

G Bristot, B Ascoli, C Gubert, B Panizzutti, F Kapczinski, A Rosa

(2014), Vol. 18, pp. 679-690, Expert Opinion on Therapeutic Targets, London, Eng., C1

Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia

A Zugno, H Chipindo, A Volpato, J Budni, A Steckert, M de Oliveira, A Heylmann, F Silveira, G Mastella, S Maravai, P Wessler, A Binatti, B Panizzutti Parry, P Schuck, J Quevedo, C Gama

(2014), Vol. 259, pp. 223-231, Neuroscience, Amsterdam, The Netherlands, C1

Staging bipolar disorder: clinical, biochemical, and functional correlates

I Grande, P Magalhaes, I Chendo, L Stertz, B Panizutti, G Colpo, A Rosa, C Gama, F Kapczinski, E Vieta

(2014), Vol. 129, pp. 437-444, Acta Psychiatrica Scandinavica, London, Eng., C1

Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects

C Gubert, L Stertz, B Pfaffenseller, B Panizzutti Parry, G Rezin, R Massuda, E Streck, C Gama, F Kapczinski, M Kunz

(2013), Vol. 47, pp. 1396-1402, Journal of psychiatric research, Amsterdam, The Netherlands, C1

Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder

B Pfaffenseller, G Fries, B Wollenhaupt-Aguiar, G Colpo, L Stertz, B Panizzutti, P Magalhães, F Kapczinski

(2013), Vol. 13, pp. 827-842, Expert Review of Neurotherapeutics, England, C1-1

Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: A study in adolescent rats with ketamine-induced model of schizophrenia

C Gama, L Canever, B Panizzutti, C Gubert, L Stertz, R Massuda, M Pedrini, D de Lucena, R Luca, D Fraga, A Heylmann, P Deroza, A Zugno

(2012), Vol. 141, pp. 162-167, Schizophrenia Research, Netherlands, C1

Maternal deprivation induces depressive-like behaviour and alters neurotrophin levels in the rat brain

G Réus, R Stringari, K Ribeiro, A Cipriano, B Panizzutti, L Stertz, C Lersch, F Kapczinski, J Quevedo

(2011), Vol. 36, pp. 460-466, Neurochemical Research, United States, C1-1